TipRanks
Go Ultimate55% OFF

InDex Pharmaceuticals Holding AB (1NP1) Cash flow

InDex Pharmaceuticals Holding AB Cash Flow

DE:1NP1's free cash flow for Q3 2026 was $500.00K. For the 2026 fiscal year, DE:1NP1's free cash flow was increased by $0.00 and operating cash flow was $500.00K. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -28.10M$ -17.00M$ -37.98M$ -129.44M$ -124.06M
$ -109.50M$ -19.80M$ -625.20M$ 0.00$ 0.00
$ -195.50M$ 571.90M$ 634.70M$ -818.00K$ 486.39M
$ 540.20M$ 865.10M$ 294.27M$ 344.93M$ 428.45M
$ -28.10M$ -17.00M$ -37.98M$ -129.44M$ -124.06M

Currency in SEK

InDex Pharmaceuticals Holding AB Cash Flow

-750M-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing